We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · May 22, 2021

Early Changes in SD-OCT After Intravitreal Aflibercept in Patients With nAMD

Retina (Philadelphia, Pa.)

 

Additional Info

Retina (Philadelphia, Pa.)
Assessment of Early Changes in Spectral Domain-Optical Coherence Tomography After Initiation of Treatment With Intravitreal Aflibercept (Eylea) Over a 12-Week Period for Patients With Neovascular Age-Related Macular Degeneration: A Multicenter French Study (START)
Retina (Philadelphia, Pa.) 2021 Mar 01;41(3)588-594, JF Korobelnik, EH Souied, H Oubraham, S Razavi, M Mauget-Faÿsse, H Savel, G Chene, S Wolf

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading